| Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasia A Katsha, M Soutto, V Sehdev, D Peng, MK Washington, MB Piazuelo, ... Gastroenterology 145 (6), 1312-1322. e8, 2013 | 107 | 2013 |
| The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells V Sehdev, DF Peng, M Soutto, MK Washington, F Revetta, J Ecsedy, ... Molecular cancer therapeutics 11 (3), 763-774, 2012 | 107 | 2012 |
| ABL regulation by AXL promotes cisplatin resistance in esophageal cancer J Hong, DF Peng, Z Chen, V Sehdev, A Belkhiri Cancer research 73 (1), 331-340, 2013 | 106 | 2013 |
| The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper … V Sehdev, A Katsha, J Ecsedy, A Zaika, A Belkhiri, W El‐Rifai Cancer 119 (4), 904-914, 2013 | 73 | 2013 |
| HDM2 regulation by AURKA promotes cell survival in gastric cancer V Sehdev, A Katsha, J Arras, D Peng, M Soutto, J Ecsedy, A Zaika, ... Clinical cancer research 20 (1), 76-86, 2014 | 69 | 2014 |
| Biochanin A modulates cell viability, invasion, and growth promoting signaling pathways in HER-2-positive breast cancer cells V Sehdev, JCK Lai, A Bhushan Journal of oncology 2009, 2009 | 61 | 2009 |
| Biochanin A reduces pancreatic cancer survival and progression V Bhardwaj, SM Tadinada, A Jain, V Sehdev, CK Daniels, JCK Lai, ... Anti-cancer drugs 25 (3), 296-302, 2014 | 46 | 2014 |
| Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells S Zhu, J Hong, MK Tripathi, V Sehdev, A Belkhiri, W El-Rifai Molecular Cancer Research 11 (1), 86-94, 2013 | 37 | 2013 |
| Omega‐3 fatty acid grafted PAMAM‐Paclitaxel conjugate exhibits enhanced anticancer activity in upper gastrointestinal cancer cells T Dichwalkar, S Patel, S Bapat, P Pancholi, N Jasani, B Desai, ... Macromolecular Bioscience 17 (8), 1600457, 2017 | 30 | 2017 |
| Omega-3 fatty acid conjugated paclitaxel dendrimers exhibit enhanced anticancer activity in various preclinical models of gastrointestinal cancers T Dichwalkar, S Bapat, P Pancholi, VK Yellepeddi, V Sehdev Cancer Research 76 (14_Supplement), 2200-2200, 2016 | 5 | 2016 |
| Selective targeting of M3 muscarinic receptors: An opportunity for improved treatment of Upper Gastrointestinal Carcinomas J Betzu, B Desai, N Jasani, V Sehdev Pharmacy & Pharmacology International Journal 1 (1), 2014 | 2 | 2014 |
| Effect of a combination of aurora kinase A inhibitor MLN-8237 and cisplatin on gastrointestinal tumors. V Sehdev, M Soutto, A Belkhiri, J Ecsedy, W El-Rifai Journal of Clinical Oncology 30 (4_suppl), 58-58, 2012 | 2 | 2012 |
| ON 123300, an orally administered novel CDK4/6+ ARK5 inhibitor, exhibits potent antitumor activity in vivo: comparative studies with Palbociclib S Patel, P Pancholi, T Visal, A Samant, D Kansara, VJ Rajadhyaksha, ... Cancer Research 77 (13_Supplement), 2172-2172, 2017 | 1 | 2017 |
| Potent anticancer activity of an orally bioavailable small molecule, ON 013100, and its water soluble derivative, briciclib, a clinical-stage eIF4E-targeted agent N Jasani, B Desai, JM Betzu, T Dichwalkar, S Bapat, VJ Rajadhayksha, ... Cancer Research 75 (15_Supplement), 1649-1649, 2015 | 1 | 2015 |
| Correction: The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells V Sehdev, D Peng, M Soutto, MK Washington, F Revetta, J Ecsedy Molecular cancer therapeutics 13 (11), 2765-2766, 2014 | 1 | 2014 |
| Differential effects of biochanin A on cell proliferation and ROS-dependent pathways in estrogen receptor positive and HER-2 positive breast cancer cells L Dickerson, V Sehdev, JCK Lai, A Bhushan Journal of the Idaho Academy of Science 49 (1), 58-59, 2013 | 1 | 2013 |
| 933 AURKA-mediated Activation of HDM2 Regulates p53 in Upper Gastrointestinal Cancers V Sehdev, AM Katsha, DF Peng, A Belkhiri, M Soutto, J Ecsedy, A Zaika, ... Gastroenterology (New York, NY 1943) 144 (5), S-167-S-167, 2013 | 1 | 2013 |
| MLN-8237 Treatment Alone and in Combination With Cisplatin Suppresses In Vitro and In Vivo Progression of Gastrointestinal Cancer Cells V Sehdev, M Soutto, A Belkhiri, J Ecsedy, W El-Rifai Gastroenterology (New York, NY 1943) 140 (5), S-121-S-121, 2011 | 1 | 2011 |
| Palbociclib synergistically enhances the anticancer activity of cisplatin in P53 mutant model of upper gastrointestinal cancers D Kansara, A Samant, P Pancholi, T Visal, S Patel, V Sehdev Cancer Research 78 (13_Supplement), 5805-5805, 2018 | | 2018 |
| Design, synthesis, selection, and evaluation of a potent multi-kinase targeting N4-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amine derivative with significant … A Samant, T Visal, P Pancholi, D Kansara, T Dichwalkar, R Senones, ... Cancer Research 78 (13_Supplement), 2800-2800, 2018 | | 2018 |
Venkata Kashyap YellepeddiAssociate Professor, Department of Pediatrics, University of UtahVerified email at utah.edu
